Method of treating asthma, allergic rhinitis, and skin disorders

The use of 5,6,7-trihydroxyheptanoic acid and analogs is disclosed for the treatment of asthma, allergic rhinitis, and skin disorders such as allergic dermatitis, contact hypersensitivity, urticaria (hives), rosacea, or psoriasis.

Saved in:
Bibliographic Details
Main Authors BRYON S. SEVERNS, CLAY BEAUREGARD, PETER G. KLIMKO
Format Patent
LanguageEnglish
Published 15.05.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The use of 5,6,7-trihydroxyheptanoic acid and analogs is disclosed for the treatment of asthma, allergic rhinitis, and skin disorders such as allergic dermatitis, contact hypersensitivity, urticaria (hives), rosacea, or psoriasis.
Bibliography:Application Number: AU20070316482